Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-09-16

Clinical Trial Update: A Study of TRV130 for the Treatment of Pain After Abdominoplasty [Phase 2]

View source ↗

Summary

Phase 2 trial of TRV130 for postoperative pain after abdominoplasty has completed and results were posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRV130 (oliceridine)

Snippet

Sponsor: Trevena Inc. | Conditions: Pain | Phase 2 | Status: COMPLETED | Results posted: 2020-09-16